Leadership Overview
Intas has 10 executives leading key functions including strategy, finance, operations, quality, human resources, and emerging markets.
Driven by a commitment to innovation, Intas focuses on the manufacturing and research of pharmaceuticals, impacting global health through its extensive product portfolio and dedication to quality.
Driven by a commitment to innovation, Intas focuses on the manufacturing and research of pharmaceuticals, impacting global health through its extensive product portfolio and dedication to quality.
Leadership Roles at Intas
Nimish Chudgar - Chief Executive Officer
Nimish Chudgar, the Chief Executive Officer at Intas, directs the company's overall strategic vision and operational execution. This leadership role involves guiding Intas's global expansion and ensuring alignment with its core mission of pharmaceutical manufacturing and research. Chudgar oversees the integration of new technologies and market opportunities, driving the company's growth trajectory. The Chief Executive Officer's responsibilities extend to fostering a culture of innovation and excellence across all departments. By championing strategic initiatives, Nimish Chudgar ensures Intas maintains its competitive edge in the global pharmaceutical landscape. This executive's focus is on maximizing shareholder value and enhancing the company's market position through decisive leadership and forward-thinking strategies.
Shivankur Mittal - Chief of Staff To Global Chief Executive Officer
Shivankur Mittal, the Chief of Staff To Global Chief Executive Officer at Intas, provides strategic support and operational coordination to the CEO. This role involves managing key initiatives, facilitating cross-functional communication, and ensuring the effective execution of the CEO's agenda across Intas's pharmaceutical manufacturing and research operations. Mittal acts as a key liaison, streamlining processes and driving project completion. The Chief of Staff's responsibilities include preparing critical reports, coordinating executive meetings, and ensuring strategic alignment throughout the organization. By enhancing operational effectiveness, Shivankur Mittal directly supports the CEO's leadership and Intas's overall business objectives. This executive's contribution is essential for maintaining organizational agility and focus.
Kshitiz Gadodia - Chief Financial Officer
Kshitiz Gadodia, the Chief Financial Officer at Intas, manages the company's financial health and strategic fiscal planning. This critical role involves overseeing all financial operations, including budgeting, forecasting, and investment strategies, directly supporting Intas's pharmaceutical manufacturing and research endeavors. Gadodia ensures robust financial controls and compliance with global regulatory standards. The Chief Financial Officer's oversight extends to optimizing capital allocation and driving profitability across all business units. By providing essential financial insights, Kshitiz Gadodia enables informed decision-making for sustainable growth. This executive's expertise is vital for navigating complex financial markets and securing the resources necessary for Intas's ongoing development and expansion.
Abhimanyu Ojha - Global Chief Financial Officer & Global President, Finance
Abhimanyu Ojha, the Global Chief Financial Officer & Global President, Finance at Intas, directs the company's comprehensive financial strategy and global fiscal operations. This executive role is paramount in managing Intas's financial resources to support its extensive pharmaceutical manufacturing and research activities worldwide. Ojha oversees financial planning, risk management, and investment portfolios, ensuring fiscal discipline and sustainable growth. The Global President, Finance's responsibilities include optimizing financial performance and compliance across all international markets. By providing strategic financial leadership, Abhimanyu Ojha ensures Intas maintains a strong financial foundation for its global operations. This executive's expertise is critical for navigating international financial landscapes and driving corporate value.
Kirti Maheshwari - Chief Operating Officer
Kirti Maheshwari, the Chief Operating Officer at Intas, directs the company's day-to-day operational activities and manufacturing processes. This leadership position is central to ensuring the efficient and high-quality production of pharmaceuticals, aligning with Intas's research and development objectives. Maheshwari oversees supply chain management, production scaling, and operational efficiency improvements across all manufacturing facilities. The Chief Operating Officer's focus includes implementing best practices to enhance productivity and reduce costs while maintaining stringent quality standards. By optimizing operational workflows, Kirti Maheshwari ensures Intas can meet global demand effectively. This executive's role is pivotal in translating strategic goals into tangible manufacturing outcomes.
Avinash Joshi - President, Quality
Avinash Joshi, the President, Quality at Intas, leads the company's unwavering commitment to product quality and regulatory compliance across all pharmaceutical manufacturing and research processes. This executive role is fundamental to upholding Intas's reputation for excellence and safety in the global healthcare market. Joshi oversees the implementation and maintenance of rigorous quality management systems, ensuring adherence to international standards. The President, Quality's responsibilities include driving continuous improvement initiatives and managing all quality assurance and control functions. By championing quality excellence, Avinash Joshi ensures that Intas's products consistently meet the highest benchmarks. This executive's dedication is vital for patient safety and regulatory approval.
Ajay Tiwari - President, Human Resources
Ajay Tiwari, the President, Human Resources at Intas, directs the company's comprehensive human capital strategy and talent management initiatives. This executive role is essential for cultivating a skilled and motivated workforce that supports Intas's pharmaceutical manufacturing and research operations. Tiwari oversees talent acquisition, employee development, and organizational culture, ensuring Intas attracts and retains top talent globally. The President, Human Resources' responsibilities include developing robust HR policies and programs that foster employee engagement and productivity. By prioritizing people, Ajay Tiwari ensures Intas has the human resources necessary to achieve its strategic objectives. This executive's leadership shapes the employee experience and organizational effectiveness.
Giridhar Venugopal - President, Emerging Markets & Bd
Giridhar Venugopal, the President, Emerging Markets & Bd at Intas, spearheads the company's strategic expansion and business development initiatives in key emerging markets. This executive role is critical for driving Intas's global growth and increasing its market penetration in diverse regions. Venugopal oversees market analysis, partnership development, and the execution of growth strategies tailored to specific regional needs within the pharmaceutical sector. The President, Emerging Markets & Bd's responsibilities include identifying new business opportunities and strengthening Intas's presence in high-potential territories. By focusing on these dynamic markets, Giridhar Venugopal ensures Intas capitalizes on global opportunities. This executive's efforts are vital for broadening the company's international footprint.
Shivam Mittal - Executive Vice President & Global Chief Information Officer
Shivam Mittal, the Executive Vice President & Global Chief Information Officer at Intas, leads the company's technology strategy and digital transformation initiatives. This executive role is crucial for enhancing Intas's pharmaceutical manufacturing and research capabilities through advanced IT infrastructure and data management. Mittal oversees the development and implementation of enterprise-wide technology solutions, ensuring data security and system reliability. The Global Chief Information Officer's responsibilities include driving innovation in digital platforms and supporting operational efficiency through technology. By leveraging cutting-edge IT, Shivam Mittal ensures Intas remains at the forefront of technological advancement in the pharmaceutical sector. This executive's vision shapes the company's digital future.
Anshu Verma - Senior General Manager, External Manufacturing (Chief Marketing Officer and CDMO)
Anshu Verma, the Senior General Manager, External Manufacturing (Chief Marketing Officer and CDMO) at Intas, manages critical aspects of external manufacturing partnerships and contract development. This role is integral to expanding Intas's production capacity and market reach through strategic collaborations in pharmaceutical manufacturing. Verma oversees the relationship management and operational integration with external partners, ensuring adherence to Intas's quality and compliance standards. The Senior General Manager's focus includes driving business development for contract manufacturing services and optimizing the external supply chain. By fostering strong external manufacturing networks, Anshu Verma enhances Intas's ability to serve a broader global market. This executive's leadership is key to leveraging external capabilities for growth.
Explore Leadership Teams in Manufacturing
Astellas Pharma is engaged in the manufacturing, marketing, import, and export of pharmaceuticals. It is headquartered in Tokyo, Japan.
Company Leadership
YC
CW
SL
Founded in 1951, Cadila Pharmaceuticals is a privately held pharmaceutical company in India. The company's integrated operations cover the entire gamut from manufacturing products ranging from API's-Intermediates, finished formulations, OTC-Food Supplements, Biotechnology Products, and pharmaceutical Machinery.
Company Leadership AT
SB
MB
JA
Cambrex is a leading global contract development and manufacturing organization (CDMO) that provides drug substance, drug product, and analytical services across the entire drug lifecycle. With over 40 years of experience and a growing team of experts servicing global clients from North America and Europe, Cambrex is a trusted partner in branded and generic markets for API and finished dosage form development and manufacturing. Cambrex offers a range of specialized drug substance technologies and capabilities, including continuous flow, controlled substances, solid-state science, material characterization, stability storage, and highly potent APIs. In addition, Cambrex can support conventional dosage forms, including oral solids, semi-solids, and liquids, and has the expertise to manufacture specialty dosage forms such as modified-release, fixed-dose combination, pediatric, bi-layer tablets, stick packs, topicals, controlled substances, sterile, and non-sterile ointments.
Company Leadership
RG
Revolution Medicines Inc is a pioneering biotechnology company committed to revolutionizing treatment for patients battling cancer. They are driven by a singular mission: the discovery, development, and delivery of innovative, targeted medicines, particularly focusing on what are known as RAS-addicted cancers, which represent a significant proportion of new human cancer diagnoses. The company has developed a groundbreaking tri-complex inhibitor platform to create a portfolio of RAS(ON) inhibitors, enabling a differentiated approach to target what was previously considered an undruggable molecular target in oncology. Through their tireless efforts and commitment to transformative science, they are building a deep pipeline of therapeutic candidates intended to change the standard of care for patients with these challenging diseases.
Company Leadership AS
SK
Frequently Asked Questions Regarding Intas Top Executives and Leadership Team
